Optometrists in Cheboygan, MI Accepting Medicare

6 Optometrists found. Showing 1 - 6

Edward P. Kosanke, Optometrist P.c Optometrist Medicare: Not Enrolled in Medicare Practice Location: 730 S Main St, Cheboygan, MI 49721 Phone: 231-627-5666

Dr. Edward Paul Kosanke, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 730 S Main St, Cheboygan, MI 49721 Phone: 231-627-5666    Fax: 231-627-5487

Dr. Travis James Elowsky, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 730 S Main St, Cheboygan, MI 49721 Phone: 989-916-5544

Elowsky Eyecare Pc Optometrist Medicare: Medicare Enrolled Practice Location: 730 S Main St, Cheboygan, MI 49721 Phone: 231-627-5666    Fax: 231-627-5487

Alpine Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 810 S Main St, Suite 3, Cheboygan, MI 49721 Phone: 231-627-3169    Fax: 231-627-3099

New Vision Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 100 S Main St, Cheboygan, MI 49721 Phone: 231-627-3149    Fax: 231-627-3855

News Archive

Drug and alcohol experts to take part in T2010 conference

In August 2010, researchers and experts on drugs, alcohol and medicines will take part in the T2010 conference, the tri-annual meeting of the International Council on Alcohol, Drugs and Traffic Safety (ICADTS). This year's meeting is being hosted by the Norwegian Institute of Public Health.

UCB receives FDA approval for Neupro to treat idiopathic Parkinson's, RLS

UCB announced today that the U.S. Food and Drug Administration (FDA) approved Neupro (Rotigotine Transdermal System) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson's disease (PD) and as a treatment for moderate-to-severe primary Restless Legs Syndrome.

FEIBA drug safe and effective for patients with hemophilia A

An international research team led by Dr. Cindy Leissinger of Tulane University School of Medicine, along with Dr. Alessandro Gringeri from the University of Milan, has found that a drug commonly used to treat bleeding events in people with a type of severe hemophilia can also be used to prevent such events from happening in the first place.

First edition: September 3, 2009

In today's headlines, President Obama announces that he will address a joint session of Congress next week in an effort to regain control of the health care reform debate.

Severe fibrosis increases early atherosclerosis risk in patients with chronic HCV-1 infection

Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty liver disease also increases risk of developing atherosclerosis at an earlier period. Both studies appear in the May issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

Read more Medical News

› Verified 4 days ago